Skip to main content

Colorectal Cancer Pathways

  • Chapter
  • First Online:
Colorectal Cancer Screening

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Genomic instability is a hallmark of colorectal cancer. Progressive accumulation of mutations leads to deregulation of cellular events, acquired growth advantage, and clonal expansion of abnormal cells. Subsequently, these cells become more susceptible to mutations increasing the likelihood of critical mutations and giving rise to histopathologically identifiable neoplastic growth and metastatic behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159–70.

    Article  PubMed  CAS  Google Scholar 

  2. Markowitz S. DNA repair defects inactivate tumor suppressor genes and induce hereditary and sporadic colon cancers. J Clin Oncol. 2000;18(21 Suppl):75S–80.

    PubMed  CAS  Google Scholar 

  3. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 2004;23(1–2):29–39.

    Article  PubMed  CAS  Google Scholar 

  4. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–87.

    Article  PubMed  CAS  Google Scholar 

  5. Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev. 2004;23(1–2):11–27.

    Article  PubMed  CAS  Google Scholar 

  6. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature. 2004;432(7015):338–41.

    Article  PubMed  CAS  Google Scholar 

  7. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135(4):1079–99.

    Article  PubMed  CAS  Google Scholar 

  8. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411(6835):366–74.

    Article  PubMed  CAS  Google Scholar 

  9. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248–57.

    PubMed  CAS  Google Scholar 

  10. Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 1999;59(9):2029–33.

    PubMed  CAS  Google Scholar 

  11. Parc YR, Halling KC, Wang L, Christensen ER, Cunningham JM, French AJ, et al. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res. 2000;60(8):2225–31.

    PubMed  CAS  Google Scholar 

  12. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol. 2003;162(4):1361–71.

    Article  PubMed  CAS  Google Scholar 

  13. Rashid A, Issa JP. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology. 2004;127(5):1578–88.

    Article  PubMed  CAS  Google Scholar 

  14. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681–6.

    Article  PubMed  CAS  Google Scholar 

  15. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38(7):787–93.

    Article  PubMed  CAS  Google Scholar 

  16. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004;4(12):988–93.

    Article  PubMed  CAS  Google Scholar 

  17. Erhardt P, Schremser EJ, Cooper GM. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol. 1999;19(8):5308–15.

    PubMed  CAS  Google Scholar 

  18. Higuchi T, Jass JR. My approach to serrated polyps of the colorectum. J Clin Pathol. 2004;57(7):682–6.

    Article  PubMed  CAS  Google Scholar 

  19. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65(14):6063–9.

    Article  PubMed  CAS  Google Scholar 

  20. Whitehall VL, Wynter CV, Walsh MD, Simms LA, Purdie D, Pandeya N, et al. Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res. 2002;62(21):6011–4.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Petr Protiva .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Protiva, P. (2011). Colorectal Cancer Pathways. In: Anderson, MD, J., Kahi, MD, C. (eds) Colorectal Cancer Screening. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60761-398-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-398-5_1

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-397-8

  • Online ISBN: 978-1-60761-398-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics